Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
PUT
Scorpio Tankers
STNG
$3.98B
| $6.65M | ﹤0.01% |
192,700
-197,100
| -51% | -$5.7M |
|
3202
Legend Biotech
LEGN
$3.95B
| $6.64M | ﹤0.01% |
120,809
+44,044
| +57% | +$1.86M |
|
3203
PUT
Martin Marietta Materials
MLM
$32.9B
| $6.64M | ﹤0.01% |
22,200
-48,000
| -68% | -$16.4M |
|
3204
PUT
Alerian MLP ETF
AMLP
$13.2B
| $6.64M | ﹤0.01% |
192,800
+9,500
| +5% | +$365K |
|
3205
CALL
Equinor
EQNR
$96.8B
| $6.64M | ﹤0.01% |
191,000
+117,800
| +161% | +$4.21M |
|
3206
MarineMax
HZO
$1.15B
| $6.64M | ﹤0.01% |
183,753
+99,626
| +118% | +$4M |
|
3207
Ambev
ABEV
$43.2B
| $6.64M | ﹤0.01% |
2,644,250
+1,203,933
| +84% | +$3.43M |
|
3208
PUT
Rocket Companies
RKT
$41.8B
| $6.63M | ﹤0.01% |
901,400
+388,200
| +76% | +$3.35M |
|
|
GOGL
3209
DELISTED
Golden Ocean Group
GOGL
| $6.63M | ﹤0.01% |
569,805
+556,755
| +4,266% | +$7.46M |
|
|
FCAX
3210
DELISTED
Fortress Capital Acquisition Corp.
FCAX
| $6.63M | ﹤0.01% |
673,062
-617,346
| -48% | -$6.07M |
|
3211
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.87B
| $6.63M | ﹤0.01% |
+278,623
| New | +$7.11M |
|
3212
PUT
Marathon Digital Holdings
MARA
$3.55B
| $6.62M | ﹤0.01% |
1,239,400
-410,600
| -25% | -$5.49M |
|
3213
PUT
Navios Maritime Partners
NMM
$2.33B
| $6.62M | ﹤0.01% |
287,700
+207,300
| +258% | +$6.05M |
|
|
RDUS
3214
DELISTED
Radius Recycling
RDUS
| $6.61M | ﹤0.01% |
+201,256
| New | +$8.58M |
|
3215
CALL
AMN Healthcare
AMN
$1.34B
| $6.61M | ﹤0.01% |
60,200
-132,700
| -69% | -$13.1M |
|
|
HZNP
3216
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.6M | ﹤0.01% |
82,800
-53,000
| -39% | -$5.02M |
|
3217
PUT
Invesco Senior Loan ETF
BKLN
$6.76B
| $6.6M | ﹤0.01% |
325,600
-325,300
| -50% | -$6.89M |
|
3218
First Trust Rising Dividend Achievers ETF
RDVY
$25.8B
| $6.6M | ﹤0.01% |
+161,254
| New | +$7.31M |
|
|
HCP
3219
CALL
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $6.59M | ﹤0.01% |
223,900
+83,500
| +59% | +$3.37M |
|
3220
Innovative Industrial Properties
IIPR
$1.62B
| $6.59M | ﹤0.01% |
59,942
-245,054
| -80% | -$34.8M |
|
3221
CALL
LGI Homes
LGIH
$1.39B
| $6.58M | ﹤0.01% |
75,700
+48,800
| +181% | +$4.52M |
|
3222
CALL
Edison International
EIX
$27.5B
| $6.58M | ﹤0.01% |
104,000
+41,400
| +66% | +$2.81M |
|
3223
PUT
Louisiana-Pacific
LPX
$5.17B
| $6.57M | ﹤0.01% |
125,400
+8,600
| +7% | +$552K |
|
|
SSAA
3224
DELISTED
Science Strategic Acquisition Corp. Alpha Class A Common Stock
SSAA
| $6.57M | ﹤0.01% |
669,333
+3,963
| +0.6% | +$38.8K |
|
3225
Granite Construction
GVA
$5.56B
| $6.56M | ﹤0.01% |
225,272
+203,610
| +940% | +$6.33M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.